- Abstract:
-
BACKGROUND: We measured plasma PCSK9 concentrations in healthy men with a PCSK9 (proprotein convertase subtilisin/kexin type 9) loss-of-function variant (p.R46L), in statin-treated patients with a clinical diagnosis of familial hypercholesterolemia (FH) and carrying a PCSK9 gain-of-function mutation (p.D374Y), and in statin-treated patients with FH due to different genetic causes. METHODS: PCSK9 was measured with a previously described ELISA. RESULTS: In 81 healthy middle-aged Caucasian men, ...
Expand abstract - Publication status:
- Published
- Journal:
- Clinical chemistry
- Volume:
- 55
- Issue:
- 12
- Pages:
- 2153-2161
- Publication date:
- 2009-12-05
- DOI:
- EISSN:
-
1530-8561
- ISSN:
-
0009-9147
- URN:
-
uuid:a3bd4997-7270-4d3a-82dd-f6079fefa432
- Source identifiers:
-
94897
- Local pid:
- pubs:94897
- Copyright date:
- 2009
Journal article
Healthy individuals carrying the PCSK9 p.R46L variant and familial hypercholesterolemia patients carrying PCSK9 p.D374Y exhibit lower plasma concentrations of PCSK9.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record